Lupin gets green light from USFDA for kidney drug Tolvaptan Ruchika Sharma24 April 2025 11:52 AM ISTMumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S. FDA) for...
Lupin recalls over 2000 bottles of antidepressant medication in US Ruchika Sharma23 April 2025 3:09 PM ISTUS: Lupin Pharmaceuticals Inc, a US-based subsidiary of Mumbai-headquartered Lupin is recalling over 2000 bottles of an antidepressant...
Lupin Diagnostics receives NABL accreditation for all Greenfield Labs Ruchika Sharma23 April 2025 11:15 AM ISTMumbai: Lupin Diagnostics Limited, a wholly owned subsidiary of global pharma major Lupin Limited, has received 100 percent National...
USFDA issues EIR for Lupin Nagpur Injectable facility Ruchika Sharma17 April 2025 3:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food...
BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes) Deeksha Bhandari11 April 2025 11:24 AM ISTRanieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd & approved in India for various...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Lupin UK arm acquires Renascience Pharma for over Rs 138 crore Ruchika Sharma3 April 2025 1:30 PM ISTMumbai: Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited, has announced the acquisition of ...
Eris Lifesciences designates Gopal Agrawal, Nita Borkar in leadership roles Ruchika Sharma2 April 2025 1:16 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
Lupin three senior executives to retire in 2 days Ruchika Sharma29 March 2025 12:15 PM ISTMumbai: Global pharmaceutical giant Lupin has announced the retirement of its three senior executives.Naresh Gupta, President – API Plus &...
Lupin awarded EcoVadis Silver Medal for sustainability excellence Ruchika Sharma21 March 2025 2:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has been awarded "Silver Medal" by EcoVadis for its outstanding sustainability...
Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine Ruchika Sharma17 March 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
